Regencell Bioscience Holdings (Regencell Bioscience Holdings) FCF Margin %

: 0.00% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Regencell Bioscience Holdings's Free Cash Flow for the six months ended in Jun. 2023 was $0.00 Mil. Regencell Bioscience Holdings's Revenue for the six months ended in Jun. 2023 was $0.00 Mil. Therefore, Regencell Bioscience Holdings's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Regencell Bioscience Holdings's current FCF Yield % is -6.91%.

The historical rank and industry rank for Regencell Bioscience Holdings's FCF Margin % or its related term are showing as below:

RGC's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -0.68
* Ranked among companies with meaningful FCF Margin % only.

Regencell Bioscience Holdings FCF Margin % Historical Data

The historical data trend for Regencell Bioscience Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %					-	-	-	-	-

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Regencell Bioscience Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regencell Bioscience Holdings FCF Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Regencell Bioscience Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Regencell Bioscience Holdings's FCF Margin % falls into.

Regencell Bioscience Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Regencell Bioscience Holdings's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-4.99	/	0
	=	%

Regencell Bioscience Holdings's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	0	/	0
	=	%

Regencell Bioscience Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.